Correlation Between Morningstar Unconstrained and Sarofim Equity

Can any of the company-specific risk be diversified away by investing in both Morningstar Unconstrained and Sarofim Equity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Morningstar Unconstrained and Sarofim Equity into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Morningstar Unconstrained Allocation and Sarofim Equity, you can compare the effects of market volatilities on Morningstar Unconstrained and Sarofim Equity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Morningstar Unconstrained with a short position of Sarofim Equity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Morningstar Unconstrained and Sarofim Equity.

Diversification Opportunities for Morningstar Unconstrained and Sarofim Equity

0.59

Correlation Coefficient

Morningstar Unconstrained  Sarofim Equity

Very weak diversification

The 3 months correlation between Morningstar and Sarofim is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Morningstar Unconstrained Allo and Sarofim Equity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sarofim Equity and Morningstar Unconstrained is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Morningstar Unconstrained Allocation are associated (or correlated) with Sarofim Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sarofim Equity has no effect on the direction of Morningstar Unconstrained i.e., Morningstar Unconstrained and Sarofim Equity go up and down completely randomly.

Pair Corralation between Morningstar Unconstrained and Sarofim Equity

Assuming the 90 days horizon Morningstar Unconstrained Allocation is expected to generate 0.9 times more return on investment than Sarofim Equity. However, Morningstar Unconstrained Allocation is 1.11 times less risky than Sarofim Equity. It trades about 0.12 of its potential returns per unit of risk. Sarofim Equity is currently generating about 0.09 per unit of risk. If you would invest  1,143  in Morningstar Unconstrained Allocation on September 2, 2024 and sell it today you would earn a total of  52.00  from holding Morningstar Unconstrained Allocation or generate 4.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Morningstar Unconstrained Allo  vs.  Sarofim Equity

Morningstar Unconstrained

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Morningstar Unconstrained Allocation are ranked lower than 9 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong basic indicators, Morningstar Unconstrained is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Sarofim Equity

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Sarofim Equity are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong primary indicators, Sarofim Equity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Morningstar Unconstrained and Sarofim Equity

The main advantage of trading using opposite Morningstar Unconstrained and Sarofim Equity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Morningstar Unconstrained position performs unexpectedly, Sarofim Equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sarofim Equity will offset losses from the drop in Sarofim Equity's long position.

The idea behind Morningstar Unconstrained Allocation and Sarofim Equity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.